The report predicts the position of the pharmaceutical industry in 2020 and suggests strategies for achieving their goals. The report found that industry returns on R&D investment reduced
The projects span over a period of three years. Patheon president and chief scientific officer Mark Kontny said Boehringer has recognized their capabilities in formulating, scaling and launching
Copaxone helps reduce the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode. During the course of the study, mice treated
The collaboration will make use of Freeslate products and services, including technology development, microscale workflows, and Freeslate’s Lab Execution and Analysis (LEA) software, which will enable gains in
The µDrop is comprised of a 16 microliter-scale plate which can examine the sample of 2 µL simultaneously and can also be used to analyze purity of the
FFG will grant 1.19 m EUR in the first year and an additional funding up to 70% of the total budget of 12.5 m EUR will be made
This is the fourth ‘Request for Proposals’ (RFP) issued through the multi-year collaboration between Fast Forward and Merck KGaA to drive the commercial development of MS therapies. Fast
Kalydeco was studied among people with CF ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator
The investigational trial is designed to assess the safety and efficacy of CD07805/47. The results demonstrated that CD07805/47 was effective in reducing facial redness. The trial also showed
According to the company, the submission would pave the way for an Investigational New Drug (IND) Application in the US. The manufacturers have produced research grade GAP-107B8 and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.